BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasprzak A, Adamek A. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy. Int J Mol Sci. 2018;19. [PMID: 30563158 DOI: 10.3390/ijms19123887] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Taha H, Elfar N, Haffez H, Hassan ZA. Raptinal silver nanoparticles: new therapeutic advances in hepatocellular carcinoma mouse model. Naunyn-Schmiedeberg's Arch Pharmacol 2021;394:279-89. [DOI: 10.1007/s00210-020-01973-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Marioni G, Blandamura S, Nicolè L, Denaro L, Cazzador D, Pavone C, Giacomelli L, Guzzardo V, Fassina A, Mazzoni A, D’avella D, Martini A, Zanoletti E. Endoglin-based assessment of neoangiogenesis in sporadic VIII cranial nerve schwannoma. Pathology - Research and Practice 2019;215:152648. [DOI: 10.1016/j.prp.2019.152648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li H. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinoma. Expert Rev Gastroenterol Hepatol 2021;15:217-33. [PMID: 33131349 DOI: 10.1080/17474124.2021.1842732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang Y, Qu H. Expression and clinical significance of aquaporin-1, vascular endothelial growth factor and microvessel density in gastric cancer. Medicine (Baltimore) 2020;99:e21883. [PMID: 32899018 DOI: 10.1097/MD.0000000000021883] [Reference Citation Analysis]
5 Tang N, Rao S, Ying Y, Huang Y. New insights into BMP9 signaling in organ fibrosis. European Journal of Pharmacology 2020;882:173291. [DOI: 10.1016/j.ejphar.2020.173291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lin YH, Lin KH, Yeh CT. Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug Resistance. Front Med (Lausanne) 2020;7:174. [PMID: 32528965 DOI: 10.3389/fmed.2020.00174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Xue C, Li G, Lu J, Luo J, Jia J. Novel insights for lncRNA MAGI2-AS3 in solid tumors. Biomed Pharmacother 2021;137:111429. [PMID: 33761624 DOI: 10.1016/j.biopha.2021.111429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Shokoohian B, Negahdari B, Aboulkheyr Es H, Abedi-Valugerdi M, Baghaei K, Agarwal T, Maiti TK, Hassan M, Najimi M, Vosough M. Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights. J Cell Mol Med 2021;25:8602-14. [PMID: 34423899 DOI: 10.1111/jcmm.16875] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Marioni G, Nicolè L, Cazzador D, Pavone C, D'avella D, Martini A, Mazzoni A, Zanoletti E. Endoglin (CD105) expression in neurofibromatosis type 2 vestibular schwannoma. Head & Neck 2019;41:3612-7. [DOI: 10.1002/hed.25881] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Xie S, Hou X, Yang W, Shi W, Yang X, Duan S, Mo F, Liu A, Wang W, Lu X. Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects. Int J Nanomedicine 2021;16:6017-34. [PMID: 34511903 DOI: 10.2147/IJN.S317220] [Reference Citation Analysis]
11 Fan Y, Xue H, Zheng H. Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook. JHC 2022;Volume 9:233-63. [DOI: 10.2147/jhc.s358082] [Reference Citation Analysis]
12 Wu D, Fan Y, Liu S, Woollam MD, Sun X, Murao E, Zha R, Prakash R, Park C, Siegel AP, Liu J, Agarwal M, Li BY, Yokota H. Loading-induced antitumor capability of murine and human urine. FASEB J 2020;34:7578-92. [PMID: 32293076 DOI: 10.1096/fj.202000096R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Jadhao M, Chen C, Liu W, Deshmukh D, Liao W, Chen JY, Urade R, Tsai E, Hsu S, Wang L, Chiu C. Endoglin Modulates TGFβR2 Induced VEGF and Proinflammatory Cytokine Axis Mediated Angiogenesis in Prolonged DEHP-Exposed Breast Cancer Cells. Biomedicines 2022;10:417. [DOI: 10.3390/biomedicines10020417] [Reference Citation Analysis]
14 Zhong L, Shi W, Gan L, Liu X, Huo Y, Wu P, Zhang Z, Wu T, Peng H, Huang Y, Zhao Y, Yuan Y, Deng Z, Tang H. Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo. Theranostics 2021;11:6393-406. [PMID: 33995664 DOI: 10.7150/thno.53121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Savarin M, Kamensek U, Znidar K, Todorovic V, Sersa G, Cemazar M. Evaluation of a Novel Plasmid for Simultaneous Gene Electrotransfer-Mediated Silencing of CD105 and CD146 in Combination with Irradiation. Int J Mol Sci 2021;22:3069. [PMID: 33802812 DOI: 10.3390/ijms22063069] [Reference Citation Analysis]
16 Siracusano G, Tagliamonte M, Buonaguro L, Lopalco L. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside. Vaccines (Basel) 2020;8:E41. [PMID: 31991677 DOI: 10.3390/vaccines8010041] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zhang Q, Wu J, Bai X, Liang T. Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas. Front Med (Lausanne). 2020;7:584250. [PMID: 33195338 DOI: 10.3389/fmed.2020.584250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Lei T, Zhang X, Du H. Characteristics, Classification, and Application of Stem Cells Derived from Human Teeth. Stem Cells Int 2021;2021:8886854. [PMID: 34194509 DOI: 10.1155/2021/8886854] [Reference Citation Analysis]
19 Jeng KS, Sheen IS, Lin SS, Leu CM, Chang CF. The Role of Endoglin in Hepatocellular Carcinoma. Int J Mol Sci 2021;22:3208. [PMID: 33809908 DOI: 10.3390/ijms22063208] [Reference Citation Analysis]
20 Egorova AA, Shtykalova SV, Maretina MA, Sokolov DI, Selkov SA, Baranov VS, Kiselev AV. Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes. Pharmaceutics 2019;11:E261. [PMID: 31174285 DOI: 10.3390/pharmaceutics11060261] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
21 Eun JW, Seo CW, Baek GO, Yoon MG, Ahn HR, Son JA, Sung S, Kim DW, Kim SS, Cho HJ, Cheong JY. Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E3819. [PMID: 33352935 DOI: 10.3390/cancers12123819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Zhao CC, Yu WW, Qi YJ, Xu LF, Wang ZR, Qiang YW, Ma F, Ma XL. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells. Anticancer Drugs 2020;31:223-30. [PMID: 31789624 DOI: 10.1097/CAD.0000000000000866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Fodor D, Jung I, Turdean S, Satala C, Gurzu S. Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study. World J Hepatol 2019; 11(3): 294-304 [PMID: 30967907 DOI: 10.4254/wjh.v11.i3.294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
24 Marioni G, Franz L, Ottaviano G, Contro G, Tealdo G, Carli A, Frigo AC, Nicolai P, Alessandrini L. Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma. Cancers (Basel) 2020;12:E2059. [PMID: 32722476 DOI: 10.3390/cancers12082059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Shoari A, Tahmasebi M, Khodabakhsh F, Cohan RA, Oghalaie A, Behdani M. Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates. International Immunopharmacology 2022;105:108585. [DOI: 10.1016/j.intimp.2022.108585] [Reference Citation Analysis]
26 Ebian HF, Issa DR, Al-karamany AS, Etewa RL, El Maghraby HM, Hussein S. Evaluation of CDCP1 (CD318) and endoglin (CD105) expression as prognostic markers in acute myeloid leukemia. CBM 2021. [DOI: 10.3233/cbm-210346] [Reference Citation Analysis]
27 Liu M, Huang Q, A J, Li L, Li X, Zhang Z, Dong JT. The Cardiac Glycoside Deslanoside Exerts Anticancer Activity in Prostate Cancer Cells by Modulating Multiple Signaling Pathways. Cancers (Basel) 2021;13:5809. [PMID: 34830961 DOI: 10.3390/cancers13225809] [Reference Citation Analysis]